ILMN Illumina, Inc. - Fundamental Analysis
NEUTRAL
ILMN Stock | Fundamental Analysis & Investment Insights
NASDAQ
•
Healthcare
•
Diagnostics & Research
Current Price
$134.35
Analyst Target
$126.94
-5.5% Downside
52W High
$153.06
52W Low
$68.7
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
68%
Analysis Accuracy
The Advanced Deterministic Scorecard shows a weak Piotroski F-Score of 4/9 and an extremely high Altman Z-Score of 32918616524.8, indicating stable financial health with no distress risk despite operational weaknesses. Illumina trades at a premium valuation (P/E 30.12 vs sector avg 37.82) with near-flat revenue growth (0.4% YoY) but strong profitability (ROE 31.2%, Gross Margin 68.38%). Earnings volatility, declining YoY EPS growth (-77.8%), and bearish insider activity offset recent positive earnings surprises and robust historical ROE. The stock is above both Graham Number ($39.52) and intrinsic value ($31.22), suggesting overvaluation unless growth rebounds significantly.
Key Strengths
Exceptionally high Altman Z-Score indicates virtually no bankruptcy risk
Strong profitability metrics: ROE of 31.2%, operating margin of 21.4%
High gross margin of 68.38% reflects pricing power and scalable business model
Recent quarterly earnings beats: 3 out of last 4 quarters exceeded estimates
Analyst consensus recommendation is 'buy' with 18 analysts covering
Key Risks
Low Piotroski F-Score of 4/9 signals weak financial momentum and deteriorating fundamentals
Significant earnings decline: YoY earnings growth down 77.8% and Q/Q down 78.7%
Near-zero revenue growth (0.4% YoY) raises concerns about top-line stagnation
High valuation multiples: P/E of 30.12 and Price/Book of 8.63 exceed sector averages
Bearish insider sentiment with net selling activity in the last 6 months
AI Fair Value Estimate
Based on comprehensive analysis
$39.52
-70.6% below current price
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare ILMN against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations